| 摘要 |
The invention relates to novel compounds having the general formula: (I) and arc useful as selective ER-beta ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis cardiovascular disease, rheumatoid arthritis or prostate cancer. |
